WEBINAR INVITATION Therapies & Hope for LMNA-related DCM Patients ![]() During this webinar, organized by DCM foundation, critical information regarding genetic components of dilated cardiomyopathy, and Pfizer’s exciting Phase 3 Clinical Trial for which they are recruiting patients with the LMNA variant will be shared. Topics of the webinar will include: – Genetics and progressive stages of DCM – Diagnosis, Evaluation of Family Disease Risk, and Treatment – Explanation of Pfizer’s Phase 3 Clinical Trial for LMNA patients – A period of interactive Q&A will follow the presentation We hope you can join DCM foundation on this interesting webinar (recorded version). Date/Time: May 18, 2022 06:00 PM in Eastern Time (US and Canada) *Note: All registrants will receive a webinar recording after the event. ![]() Speaker: Calum MacRae, MD, PhD from Brigham and Women’s Hospital, Boston Register for free (closed) – watch the recorded version ![]() |